IMIM (Hospital del Mar Medical Research Institute), located at the Barcelona Biomedical Research Park (PRBB) is, up to 82%, made up of research groups lead by professionals from the MAR Health Park , most of whom are associates of the Autonomous University of Barcelona (UAB) and the Pompeu Fabra University (UPF), as well as other seconded staff members from the Centre for Research in Environmental Epidemiology (CREAL), the Centre for Genomic Regulation (CRG), the Department of Experimental and Health Sciences of the Pompeu Fabra University (DCEXS-UPF), the Centre of Regenerative Medicine in Barcelona (CMRB) and the Barcelona Biomedical Research Park (PRBB).
On 16 December 2013, the Accreditation Committee of the Carlos III Health Institute (ISCIII) approved the acreditation of IMIM as a Health Research Institute, which was ratified by the State Secretarial of Research, Development and Innovation for the Order of 17 February 2014.
At IMIM there are around seven hundred professionals, of which one hundred and nineteen are lead researchers distributed in fifty-six research groups integrated into the five multi-disciplinary programmes framing research activities within IMIM:
Cancer, directed by Joan Albanell
Epidemiology and Public Health, directed by Jordi Alonso
Cardiovascular and inflammatory processes, directed by Miguel López-Botet
Biomedical Informatics, directed by Ferran Sanz
Neurosciences, directed by Rafael de la Torre
A large proportion of its budget is provided by external competitive funds that are managed by the Mar Institute of Medical Research Foundation.
The scientific output generate from this research includes almost 550 annual papers in international journals indexed in the Science Citation Index (SCI). Another relevant fact is that 65% of the IMIM papers are published in journals that are in the top quartile of their category.
IMIM has a Scientific Advisory Board (SAB) made up of a group of prestigious international expert scientists from the different areas of the IMIM research programmes.
IMIM Institut Recerca Hospital del Mar
14 followers
5 publications
IMIM Institut Recerca Hospital del Mar posted this:
14 followers
Patents for licensing
- +4 months
- Hide post
IMIM Institut Recerca Hospital del Mar
14 followers
5 publications
IMIM Institut Recerca Hospital del Mar posted this:
14 followers
New phenolic natural extract obtained from olive and herbal spices with proven cardioprotective effect.
Innovative Products and Technologies
- +6 months
- Hide post
IMIM Institut Recerca Hospital del Mar
14 followers
5 publications
IMIM Institut Recerca Hospital del Mar posted this:
14 followers
New method for the determination of the risk of atypical fractures in patients treated with bone remodelling inhibitors.
Patents for licensing
- +6 months
- Hide post
IMIM Institut Recerca Hospital del Mar
14 followers
5 publications
IMIM Institut Recerca Hospital del Mar posted this:
14 followers
A prognostic and predictive serum biomarker in Small Cell Lung Cancer
Patents for licensing
- +6 months
- Hide post